Shira Zelber-Sagi
Epidemiology · 2009–2021
A researcher in the Science corpus: 6 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 74 citations into it
- Hepatology — 41 citations into it
- Pathology and Forensic Medicine — 19 citations into it
Whom Shira Zelber-Sagi trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Shira Zelber-Sagi's perspective
Ordered by how strongly the researchers Shira Zelber-Sagi trusts endorse each paper. Same corpus, a different order for every researcher.
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the… (American Journal of Gastroenterology)
- Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials (Diabetologia)
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. (The Lancet)
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. (Gastroenterology)
- Sampling variability of liver biopsy in nonalcoholic fatty liver disease. (Gastroenterology)
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (Obesity Facts)
- Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis (New England Journal of Medicine)
- Advanced glycoxidation end products in commonly consumed foods. (Journal of the American Dietetic Association)
- Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. (Journal of Clinical Oncology)
Their papers
- Advancing the global public health agenda for NAFLD: a consensus statement (2021) — 631 citations
- A new definition for metabolic associated fatty liver disease: an international expert consensus statement. (2020) — 3,051 citations
- The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2020) — 1,072 citations
- EASL Clinical Practice Guidelines on nutrition in chronic liver disease (2018) — 863 citations
- Treatment of NAFLD with diet, physical activity and exercise. (2017) — 1,185 citations
- Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. (2009) — 297 citations